A fair price for drugs - WHEB

Ted Franks, Partner and Fund Manager, explores the changing US healthcare industry, with a focus on the cost of drugs.

Only members with restricted access (ie. academics, asset owners, government and regulatory, independent advisers/trustees and sponsoring employers) can view this article. Please login or join to view.

... To read more of this commentary, please click on the button below. 

Learn more here